Piper Sandler analyst Kashy Harrison upgrades Comstock Res (NYSE:CRK) from Underweight to Neutral and raises the price target from $16 to $17.
Material Weakness In Internal Control: Dentsply Stock Falls Despite Q2 Beat – What’s Going On
Dentsply Sirona Inc (NASDAQ: XRAY) reported Q2 adjusted EPS of $0.51, down 26% from $0.69 a year ago, beating the consensus